View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Research Department
  • Research Department

IBERIAN DAILY 25 APRIL + 1Q'25 RESULTS. PREVIEWS (ANÁLISIS BANCO SABAD...

NEWS SUMMARY: FERROVIAL, INDRA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’25 results to be released over the coming days in Spain. The Euro STOXX 50 consolidates at the 5,100-point level European stock markets rose, seeing an increasing performance. In the STOXX 600, cyclical sectors such as Autos and Basic Resources were the best performers whereas Banks and Telecoms ...

Research Department
  • Research Department

INFORME DIARIO 25 ABRIL + RDOS. ESPAÑA Y EUROPA 1T’25. PREVIEWS (ANÁLI...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FERROVIAL, INDRA. EUROPA: DEUTSCHE TELEKOM, SAFRAN, UNICREDIT, VINCI. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’25 que se publicarán en España y Europa en los próximos días. El Euro STOXX 50 se asienta en los 5.100 puntos Subidas en las bolsas europeas, en una jornada de menos a más. En el STOXX 600...

Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
Damien Choplain ... (+2)
  • Damien Choplain
  • Martial Descoutures
Rafael Bonardell
  • Rafael Bonardell

SANOFI: RDOS. 1T’25 Y CAMBIO DE RECOMENDACIÓN A SOBREPONDERAR Y DE P.O...

Rdos. 1T'25 vs 1T'24: Ventas: 9.895 M euros (+10,8% vs +7,5% BS(e) y +8,5% consenso); EBIT: 2.902 M euros (+20,1% vs +12,0% BS(e) y +12,5% consenso).

Research Department
  • Research Department

IBERIAN DAILY 24 APRIL + 1Q'25 RESULTS. PREVIEWS (ANÁLISIS BANCO SABAD...

NEWS SUMMARY: BANKINTER, ELECTRICITY SECTOR, INDRA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’25 results to be released over the coming days in Spain. Renewed optimism in European stock markets European stock markets rallied, fuelled by the lower risk perception about tariffs. Within the STOXX 600, almost all sectors (16/20) saw gains, led by Technology and Banks, whe...

Research Department
  • Research Department

INFORME DIARIO 24 ABRIL + RDOS. ESPAÑA Y EUROPA 1T'25. PREVIEWS (ANÁLI...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: BANKINTER, INDRA, SECTOR ELÉCTRICO. EUROPA: ADIDAS, AIR LIQUIDE, BNP, ENI, ESSILORLUXOTTICA, KERING, NOKIA. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’25 que se publicarán en España y Europa en los próximos días. El optimismo vuelve a las bolsas europeas Fuerte rebote de las bolsas europeas, impulsad...

 PRESS RELEASE

Press Release: Sanofi: strong Q1 performance and 2025 guidance confirm...

Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed Sanofi: strong Q1 performance and 2025 guidance confirmed Paris, April 24, 2025 Q1 sales growth of 9.7% at CER1 and business EPS2 of €1.79 Pharma launches reached sales of €0.8 billion, up 43.8%, driven by ALTUVIIIODupixent sales were €3.5 billion, up 20.3%Vaccines sales were €1.3 billion, up 11.4%, driven by favorable Beyfortus phasingResearch and Development expenses reached €1.8 billion, up 6.9%Selling, general and administrative expenses were €2.2 billion, up 3.8%Business EPS was €1.79, up 15.7% at CER and up 17...

 PRESS RELEASE

Communiqué de presse : Sanofi : forte performance au T1 et confirmatio...

Communiqué de presse : Sanofi : forte performance au T1 et confirmation des perspectives pour 2025 Sanofi : forte performance au T1 et confirmation des perspectives pour 2025 Paris, le 24 avril 2025 Ventes du T1 en progression de 9,7 % à TCC1 et BNPA2 des activités de 1,79 euro Les ventes des nouveaux lancements pharmaceutiques atteignent 0,8 milliard d’euros (+43,8 %), portées par ALTUVIIIOLes ventes de Dupixent progressent à 3,5 milliards d’euros (+20,3 %)Les ventes des Vaccins augmentent à 1,3 milliard d’euros (+11,4 %), portées par des séquences favorables pour BeyfortusLes frais de ...

Research Department
  • Research Department

IBERIAN DAILY 23 APRIL + 1Q’25 RESULTS. PREVIEWS (ANÁLISIS BANCO SABAD...

NEWS SUMMARY: COLONIAL, SANTANDER. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 1Q’25 results to be released over the coming days in Spain. US stock markets try to recover European stock markets ended with gains of 0.5%, benefiting from the US rally where the 1Q’25 earnings season is improving slightly. Within the STOXX 600, Consumer Goods and Basic Resources were the best p...

Research Department
  • Research Department

INFORME DIARIO 23 ABRIL + RDOS. ESPAÑA Y EUROPA 1T’25. PREVIEWS (ANÁLI...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: COLONIAL, SANTANDER. EUROPA: DANONE, SAP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’25 que se publicarán en España y Europa en los próximos días. EE.UU. intenta recuperarse Las bolsas europeas terminaron con subidas de medio punto, beneficiadas por el rebote de EE.UU. donde la temporada de resultado...

Arancha Pineiro
  • Arancha Pineiro

L’ORÉAL: VENTAS 1T’25, CAMBIO DE RECOMENDACIÓN A SOBREPONDERAR Y DE P....

Ventas 1T'25 vs 1T'24: Ventas: 11.735 M euros (+4,4% vs +2,5% BS(e) y +1,7% consenso).

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch